Inactive Instrument

Sedana Medical AB (publ) Stock Nasdaq Stockholm

Equities

SE0009947534

Medical Equipment, Supplies & Distribution

Sales 2024 * 181M 16.68M Sales 2025 * 243M 22.38M Capitalization 1.45B 133M
Net income 2024 * -61M -5.62M Net income 2025 * -35M -3.23M EV / Sales 2024 * 7.37 x
Net cash position 2024 * 113M 10.44M Net cash position 2025 * 81.11M 7.47M EV / Sales 2025 * 5.62 x
P/E ratio 2024 *
-23.4 x
P/E ratio 2025 *
-42.2 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 63.5%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Sedana Medical AB (publ)

Managers TitleAgeSince
Chief Executive Officer 43 21-09-30
Director of Finance/CFO - 22-04-03
Chief Tech/Sci/R&D Officer 53 20-10-31
Members of the board TitleAgeSince
Director/Board Member 65 21-12-31
Director/Board Member 49 20-05-18
Chairman 53 21-05-09
More insiders
Sedana Medical AB (publ) is a Sweden-based medical technology company. It develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.
More about the company